Clinical Immunology · STAT3 Gain-of-Function Syndrome

The Biology of STAT3-GOF and How It's Diagnosed

At a Glance

STAT3-GOF is diagnosed by combining a child’s pattern of early-onset autoimmunity, growth problems, and immune findings with genetic testing for a STAT3 variant. Functional tests may help determine whether the variant makes STAT3 overactive and distinguish it from ALPS or Job syndrome.

To understand STAT3 Gain-of-Function (STAT3-GOF) syndrome, it helps to look at the “instruction manual” for your child’s immune system. The STAT3 gene provides instructions for a protein that acts as a critical messenger. In a healthy system, this messenger tells cells when to grow, when to fight, and when to rest.

In STAT3-GOF, a genetic change causes this messenger to be overactive. It is as if the immune system’s “on switch” is not just flipped on, but has been glued in that position ^[1]^[2].

The Biology of an Overactive Switch

When the STAT3 protein is constantly active, it changes the balance of different types of immune cells. Research is ongoing, but studies have identified several reported abnormalities (which can be variant- and context-dependent):

The Th17/Treg Imbalance: STAT3-GOF often boosts the production of Th17 cells, which are “pro-inflammatory” cells that help fight certain infections but can cause inflammation if there are too many of them ^[3]^[4]. At the same time, it can reduce or impair T-regulatory (Treg) cells, which are the “peacekeeper” cells responsible for calming the immune system down ^[5]^[6].
Failed “Cellular Cleanup”: Normally, the body has a process called apoptosis—a way to safely remove old or overactive immune cells. In STAT3-GOF, altered signaling has been proposed to make some immune cells resistant to this cleanup process, leading them to build up in the lymph nodes and spleen ^[7].
Innate Cell Defects: Beyond the T cells, STAT3-GOF can also interfere with the development of “innate” immune cells (like monocytes and dendritic cells), which are the body’s first line of defense. This explains why children can have both an overactive immune system (autoimmunity) and a hard time fighting certain germs (immunodeficiency) ^[8].

(Glossary: “Constitutive phosphorylation” means the STAT3 protein is stuck in its active state without needing a signal; “delayed dephosphorylation” means it turns on normally but takes too long to turn off; “transcriptional reporter activity” tests how strongly the protein sends signals to the DNA; “zygosity” refers to whether you have one or two copies of the genetic variant.)

Telling Disorders Apart

Because STAT3-GOF is so rare, it is often mistaken for other conditions during the diagnostic process.

Feature	STAT3-GOF (Gain-of-Function)	STAT3-LOF (Job Syndrome)	ALPS (Classical)
Mechanism	Enhanced/prolonged STAT3 signaling ^[9]	Defective STAT3 signaling ^[10]	Defective “cleanup” (FAS pathway) ^[11]
Growth	Often causes growth failure ^[12]	Usually normal height	Usually normal height
IgE Levels	Usually normal or low ^[10]	Extremely high IgE ^[10]^[13]	Usually normal
Key Symptoms	Polyautoimmunity, small stature	Skin abscesses, eczema, pneumonia	Large lymph nodes/spleen

STAT3 Loss-of-Function (LOF), also known as Job Syndrome, is essentially the opposite of STAT3-GOF. While STAT3-GOF causes the body to attack itself, LOF makes the body fail to respond to threats, leading to frequent skin abscesses and severe eczema ^[10]^[13].

ALPS (Autoimmune Lymphoproliferative Syndrome) is a very close “look-alike.” About 83% of children tested in a large STAT3-GOF cohort had high levels of double-negative T cells, which is the hallmark laboratory sign of ALPS ^[9]. However, elevated double-negative T cells are not specific for ALPS or STAT3-GOF. Doctors must use genetic testing to tell them apart, as the treatments for these two conditions can be very different.

How the Diagnosis is Confirmed

A diagnosis of STAT3-GOF is rarely made with a single blood draw. It typically involves a three-step process:

Clinical Picture: Identifying a pattern of early-onset autoimmunity, growth issues, and enlarged lymph nodes ^[9].
Genetic Testing: Using Whole Exome Sequencing (WES) or an immune gene panel to find a variant in the STAT3 gene ^[14]^[15]. A Variant of Uncertain Significance (VUS) is not a diagnosis until a genetics and immunology team interprets it alongside the patient’s symptoms.
Functional Assays: Since some genetic changes are harmless, specialists at specialized/research labs may use tests to see if the variant changes how the protein works. These might include checking phosphorylation kinetics or an IL-10 inhibition assay ^[1]^[16]. These tests are not uniformly standardized or required for every patient.

STAT3-GOF is generally inherited in an autosomal-dominant pattern, meaning only one affected copy is needed to cause disease. However, many cases are de novo, meaning the variant occurred spontaneously in the child ^[17]. Biological parents and affected relatives should undergo testing, and genetic counseling is important to understand recurrence and reproductive options.

Diagnostic Completeness Checklist

When you receive your child’s lab and pathology reports, ensure the following information is included. You do not need to check every box yourself, as the necessity of specialized tests varies, but this data is vital for your specialists.

Genetic Report:
- [ ] The exact protein change (e.g., STAT3 p.T716M).
- [ ] Inheritance status (whether it was “de novo”—new in the child—or inherited, which often requires parental testing).
Immune Panel:
- [ ] Alpha-beta double-negative T cell (DNT) count and percentage.
- [ ] Quantitative Immunoglobulins (IgG, IgA, IgM, and IgE).
Blood Counts:
- [ ] CBC with differential (to look for low platelets or red blood cells).
- [ ] Reticulocyte count (to see if the body is making new red blood cells).

Common questions in this guide

What is STAT3-GOF syndrome?

STAT3-GOF syndrome is a rare immune disorder caused by a change in the STAT3 gene that leaves the STAT3 protein too active. It can cause early-onset autoimmunity, growth problems, enlarged lymph nodes, and difficulty fighting some infections.

How do doctors confirm STAT3-GOF?

Doctors combine a child's symptoms and immune findings with genetic testing, usually whole exome sequencing or an immune gene panel. A specialized functional assay may help show whether the variant changes STAT3 activity, but these tests are not standardized or needed for every patient.

Does a STAT3 variant of uncertain significance confirm the diagnosis?

No. A variant of uncertain significance means there is not enough evidence to know whether the genetic change causes disease. A genetics and immunology team must interpret it alongside the child's clinical findings and, when available, functional test results.

How is STAT3-GOF different from ALPS or Job Syndrome?

STAT3-GOF involves enhanced or prolonged STAT3 signaling, while Job Syndrome results from reduced STAT3 signaling and ALPS usually involves a problem in the FAS cell-cleanup pathway. Double-negative T cells may be high in both STAT3-GOF and ALPS, so genetic testing and the overall clinical picture are needed to tell them apart.

Is STAT3-GOF inherited, or can it occur for the first time in a child?

STAT3-GOF is generally autosomal dominant, so one altered copy can be enough to cause the condition. Many children have a de novo variant that arose spontaneously, but parental and family testing can clarify inheritance and support genetic counseling.

What tests should be reviewed when evaluating STAT3-GOF?

The genetic report should list the exact protein change and whether the variant is de novo or inherited. Immune evaluation may include the double-negative T-cell count and IgG, IgA, IgM, and IgE levels, while blood testing may include a CBC with differential and reticulocyte count.

Get notified when new evidence is published on STAT3-related early-onset multisystem autoimmune disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (17)

1
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.
Jägle S, Heeg M, Grün S, et al.
Clinical immunology (Orlando, Fla.) 2020; (210()):108316 doi:10.1016/j.clim.2019.108316.
PMID: 31770611
2
Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations.
Gutiérrez M, Scaglia P, Keselman A, et al.
Molecular and cellular endocrinology 2018; (473()):166-177 doi:10.1016/j.mce.2018.01.016.
PMID: 29378236
3
A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice.
Schmitt EG, Toth KA, Risma SI, et al.
JCI insight 2022; (7(21)).
PMID: 36136607
4
Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction.
Woods J, Pemberton SE, Largent AD, et al.
Journal of immunology (Baltimore, Md. : 1950) 2022; (209(6)):1033-1038 doi:10.4049/jimmunol.2100920.
PMID: 35995509
5
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.
Baumgartner F, Bamopoulos SA, Faletti L, et al.
Science signaling 2024; (17(824)):eadc9662 doi:10.1126/scisignal.adc9662.
PMID: 38377177
6
Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
Marega LF, Sabino JS, Pedroni MV, et al.
Immunologic research 2021; (69(5)):445-456 doi:10.1007/s12026-021-09225-0.
PMID: 34390446
7
STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds.
Nabhani S, Schipp C, Miskin H, et al.
Clinical immunology (Orlando, Fla.) 2017; (181()):32-42 doi:10.1016/j.clim.2017.05.021.
PMID: 28579554
8
STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells.
Korenfeld D, Roussak K, Dinkel S, et al.
Journal of immunology (Baltimore, Md. : 1950) 2021; (207(10)):2423-2432 doi:10.4049/jimmunol.2000841.
PMID: 34654687
9
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW, Vogel TP, Santarlas VGJ, et al.
The Journal of allergy and clinical immunology 2023; (151(4)):1081-1095 doi:10.1016/j.jaci.2022.09.002.
PMID: 36228738
10
Dominant-Negative Versus Gain-of-Function STAT3 Defects: A Systematic Review on Epidemiological, Clinical, Immunological, and Molecular Aspects.
Hajialigol A, Azizi G, Seifi Alan M, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(6)):1440-1448.e4 doi:10.1016/j.jaip.2025.04.014.
PMID: 40246075
11
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
Casamayor-Polo L, López-Nevado M, Paz-Artal E, et al.
Critical reviews in clinical laboratory sciences 2021; (58(4)):253-274 doi:10.1080/10408363.2020.1855623.
PMID: 33356695
12
Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.
Fabre A, Marchal S, Barlogis V, et al.
The journal of allergy and clinical immunology. In practice 2019; (7(6)):1958-1969.e9 doi:10.1016/j.jaip.2019.02.018.
PMID: 30825606
13
STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.
Lorenzini T, Dotta L, Giacomelli M, et al.
Journal of leukocyte biology 2017; (101(1)):29-38 doi:10.1189/jlb.5RI0516-237RR.
PMID: 27803128
14
Case Report: Dual molecular diagnosis of gain-of-function STAT1 mutation and regulatory STAT3 variant in a patient with a hyper-IgE-like phenotype.
Yaakoubi R, Mekki N, Ben Chehida A, et al.
Frontiers in immunology 2025; (16()):1646761 doi:10.3389/fimmu.2025.1646761.
PMID: 41112238
15
STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection.
Gonzalez-Mancera MS, Johnson B, Mirsaeidi M
Respiratory medicine case reports 2020; (30()):101125 doi:10.1016/j.rmcr.2020.101125.
PMID: 32577366
16
Disease-causing STAT3 variants can be discriminated by a functional flow cytometry test.
Esteve-Sole A, Freeman AF, Hsu A, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(2)):e70300 doi:10.1111/pai.70300.
PMID: 41644831
17
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K, Sakura F, Nambu R, et al.
Journal of clinical immunology 2021; (41(4)):780-790 doi:10.1007/s10875-021-00975-y.
PMID: 33501615

This page explains the biology and diagnosis of STAT3-GOF for informational purposes only and does not constitute medical advice. A clinical immunologist and genetics team should interpret your child's results and guide care.